Array BioPharma Competitors and Similar CompaniesClear all
Amicus Therapeutics's competitors and similar companies include Durect.
 Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Cupertino, US HQ |
Employees | Employees 58415% increase | Employees 902% increase |
Valuation ($) | Valuation ($) 3.4 b | Valuation ($) 45.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $634.2m (FY, 2025) | Revenue (est.) $2m (FY, 2024) |
Cost of goods | Cost of goods $72.9m (FY, 2025) | Cost of goods $78k (FY, 2024) |
Gross profit | Gross profit $561.3m (FY, 2025) | Gross profit $2m (FY, 2024) |
Net income | Net income ($27.1m) (FY, 2025) | Net income ($8.3m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 88m | Total funding raised $ 20m |
For sources of this data, please see the company profile
View Company Profiles
Durect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View company